Hutch News

Hutch News

Stories tagged 'Antonio Bedalov'

Reawakening the X chromosome: New possible therapeutic targets for Rett syndrome

Study points to potential reversal of rare childhood neurological disorder by reactivating silenced copy of the disease-linked gene

Jan. 30, 2017 | By Rachel Tompa / Fred Hutch News Service

A research team led by Fred Hutch's Dr. Antonio Bedalov have uncovered 30 genes that could, one day, serve as therapeutic targets to reverse Rett syndrome, a rare neurological disorder that affects primarily girls and women. The new findings are described in a study published today in the journal Proceedings of the National Academy of Sciences.

View story >

Dr. Antonio Bedalov wins award for translational research

Ignition Award helps to fund projects that show promise for sparking new grant applications or future pre-clinical and clinical studies

March 2, 2009

Dr. Antonio Bedalov of the Fred Hutchinson Cancer Research Center is among the first three recipients of the University of Washington School of Pharmacy’s Ignition Awards. Bedalov will lead a study titled "Identification of Pharmacodynamic Biomarkers for Inhibitors of NAD-dependent Protein Deacetylases Using Mass Spectrometry."

View story >

Bedalov's journey from Split to splitomicin and beyond

Toni Bedalov investigates drug candidates for anticancer therapy in breast-cancer malignancies, illuminates the molecular process of gene silencing

Aug. 4, 2005 | By CHRISTINE LOFTUS

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.